Michael LaValley
Profiles

Michael P Lavalley, PhD

Professor, Biostatistics - Boston University School of Public Health

mlava@bu.edu

Biography

Michael LaValley, PhD. is a Professor of Biostatistics at the Boston University School of Public Health, where he teaches courses on meta-analysis, logistic regression, and survival analysis. Mike’s research efforts are focused on meta-analysis of study results, analysis of ordered categorical data, survival analysis, clinical trials, and outcome assessment in arthritis studies. He has also served as a Peace Corps Volunteer math and science teacher in Nepal in the late 1980s. He has a BA in Mathematics from American International College, a MA in Mathematics from Ohio State University, and a Ph.D. in Statistics from Penn State University. He joined the faculty at Boston University after completing a postdoctoral fellowship in Biostatistics at the Harvard School of Public Health.

Mike serves as the Research Director of the Boston University Core Center for Clinical Research, is the co-lead of the Analysis Core for the Multicenter Osteoarthritis Study (MOST) and is a Member of the Arthritis and Musculoskeletal and Skin Diseases Clinical Trials Study Section (AMSC) for the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).

Other Positions

  • Member, Arthritis & Autoimmune Diseases Research Center - Boston University
  • - Boston Medical Center

Education

  • Pennsylvania State University, PhD Field of Study: Statistics
  • Ohio State University, MS Field of Study: Mathematics
  • American International College, BA Field of Study: Mathematics

Classes Taught

  • SPHBS810
  • SPHBS820

Publications

  • Published on 9/10/2025

    Ruberg FL, Teruya S, Helmke S, Smiley DA, Fine D, Kurian D, Raiszadeh F, Prokaeva T, Spencer B, Wong S, Pandey S, Blaner WS, DeLuca A, Johnson LL, Kinkhabwala MP, Leb J, Mintz A, LaValley MP, Einstein AJ, Cohn E, Gallegos C, Murtagh G, Kelly JW, Miller EJ, Maurer MS. Transthyretin Cardiac Amyloidosis in Older Black and Hispanic Individuals With Heart Failure. JAMA Cardiol. 2025 Sep 10. PMID: 40928765.

    Read At: PubMed
  • Published on 8/12/2025

    Aoyagi K, Wang N, LaValley M, Tilley S, Frey-Law L, Lewis CE, Nevitt M, Neogi T. Longitudinal Trajectories of Pain Sensitization Over Nine Years in People With or at Risk of Knee Osteoarthritis. Arthritis Care Res (Hoboken). 2025 Aug 12. PMID: 40790991.

    Read At: PubMed
  • Published on 8/4/2025

    Wu Y, Liew JW, Boer JD, Westerland M, LaValley M, Voortman T, Bierma-Zeinstra S, Oei EHG, van Meurs JBJ, Neogi T, Boer CG. Chondrocalcinosis and incident knee osteoarthritis: findings from 2 large prospective cohorts with 20 years of follow-up. Ann Rheum Dis. 2025 Aug 04. PMID: 40764183.

    Read At: PubMed
  • Published on 8/4/2025

    Lang R, Humes E, Lyass A, Borowsky LH, Hogan B, Kim A, LaValley M, Silverberg MJ, Kim HN, Napravnik S, Moore RD, Horberg MA, Palella FJ, Kirk GD, Cachay E, Yendewa GA, Kassaye S, McGinnis K, Coburn SB, Sterling TR, Klein MB, Kitahata MM, Lesko C, Triant VA, Althoff KN. Direct-Acting Antiviral Initiation Among People With Hepatitis C Virus (HCV) and HIV on Antiretroviral Therapy in the United States and Canada: Factors Driving the HCV Treatment Gap. Open Forum Infect Dis. 2025 Aug; 12(8):ofaf454. PMID: 40893421.

    Read At: PubMed
  • Published on 8/1/2025

    James KA, Corrigan P, Huang CH, Lanois C, LaValley MP, Davis IS, Stefanik JJ. Gait Retraining to Reduce Tibial Acceleration Versus a Standard Walking Program for Reducing Knee Pain and Loading in Adults With Knee Osteoarthritis: A Randomized Feasibility Trial. ACR Open Rheumatol. 2025 Aug; 7(8):e70079. PMID: 40728103.

    Read At: PubMed
  • Published on 7/31/2025

    Lui JK, El-Adili F, Cozzolino M, Winburn M, Trojanowski MA, Gopal DM, LaValley MP, Klings ES, Bujor AM. A multi-biomarker approach to risk stratification and detection of early cardiac disease in systemic sclerosis. PLoS One. 2025; 20(7):e0328734. PMID: 40743121.

    Read At: PubMed
  • Published on 7/2/2025

    Woodhouse EW, Alsoubani M, Roach DJ, Flynn DB, LaValley M, Sheridan K, Hooper DC, Fowler VG, Duffy EM, Grossman TH. Infection Risk Associated With Colonization by Multidrug-Resistant Gram-Negative Bacteria: An Umbrella Review and Meta-analysis. Open Forum Infect Dis. 2025 Jul; 12(7):ofaf365. PMID: 40689244.

    Read At: PubMed
  • Published on 7/1/2025

    Sherman DA, Neogi T, Hornsby S, Felson D, Lavalley M, Stefanik JJ. Association of Knee Pain Frequency and Severity with Quadriceps Strength but Not Rate of Decline Over Four Years. ACR Open Rheumatol. 2025 Jul; 7(7):e70067. PMID: 40586171.

    Read At: PubMed
  • Published on 6/30/2025

    Parkes MJ, Felson DT, LaValley MP. Increasing Placebo Response Rates and the Threat to Clinical Trials: How Will We Identify Effective Treatments for Rheumatic Disorders? Arthritis Rheumatol. 2025 Jun 30. PMID: 40583535.

    Read At: PubMed
  • Published on 4/11/2025

    Sara LK, Felson DT, Tilley S, LaValley MP, Lewis CE, Lynch JA, Segal NA, Guermazi A, Roemer F, Stefanik JJ, Lewis CL. The relation of walking forces to structural damage in the knee: The Multicenter Osteoarthritis Study. Osteoarthritis Cartilage. 2025 Jun; 33(6):745-752. PMID: 40222627.

    Read At: PubMed

News & In the Media